These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 35084674)

  • 1. Mechanisms contributing to adverse outcomes of COVID-19 in obesity.
    Sudhakar M; Winfred SB; Meiyazhagan G; Venkatachalam DP
    Mol Cell Biochem; 2022 Apr; 477(4):1155-1193. PubMed ID: 35084674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
    Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
    Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.
    Krams IA; Jõers P; Luoto S; Trakimas G; Lietuvietis V; Krams R; Kaminska I; Rantala MJ; Krama T
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33503828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular dysfunction pathophysiology in COVID-19.
    Yin J; Wang S; Liu Y; Chen J; Li D; Xu T
    Microcirculation; 2021 Oct; 28(7):e12718. PubMed ID: 34013612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury.
    Lasbleiz A; Gaborit B; Soghomonian A; Bartoli A; Ancel P; Jacquier A; Dutour A
    Front Endocrinol (Lausanne); 2021; 12():726967. PubMed ID: 34484128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
    Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
    Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
    Nägele MP; Haubner B; Tanner FC; Ruschitzka F; Flammer AJ
    Atherosclerosis; 2020 Dec; 314():58-62. PubMed ID: 33161318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
    Shah H; Khan MSH; Dhurandhar NV; Hegde V
    Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and ethnicity: A novel pathophysiological role for inflammation.
    Vepa A; Bae JP; Ahmed F; Pareek M; Khunti K
    Diabetes Metab Syndr; 2020; 14(5):1043-1051. PubMed ID: 32640416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity in patients with COVID-19: a systematic review and meta-analysis.
    Huang Y; Lu Y; Huang YM; Wang M; Ling W; Sui Y; Zhao HL
    Metabolism; 2020 Dec; 113():154378. PubMed ID: 33002478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.
    Patel KHK; Li X; Quint JK; Ware JS; Peters NS; Ng FS
    BMC Endocr Disord; 2021 Jul; 21(1):144. PubMed ID: 34217276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral adiposopathy: a vascular perspective.
    Farb MG; Gokce N
    Horm Mol Biol Clin Investig; 2015 Feb; 21(2):125-36. PubMed ID: 25781557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and the role of chronic inflammation in patients with obesity.
    Chiappetta S; Sharma AM; Bottino V; Stier C
    Int J Obes (Lond); 2020 Aug; 44(8):1790-1792. PubMed ID: 32409680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Obesity and COVID-19: A Detrimental Intersection.
    Gammone MA; D'Orazio N
    Front Endocrinol (Lausanne); 2021; 12():652639. PubMed ID: 33995281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.